Full Text View
Tabular View
No Study Results Posted
Related Studies
Dopaminergic Effects on Cortical Function in Tourette's (Levodopa Protocol) (TSfMRI)
This study has been completed.
Study NCT00634556   Information provided by Washington University School of Medicine

First Received on March 5, 2008.   Last Updated on June 11, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Tourette Syndrome
More general conditions related to this trial
Basal Ganglia Diseases
Brain Diseases
Central Nervous System Diseases
Genetic Diseases, Inborn
Heredodegenerative Disorders, Nervous System
Mental Disorders
Mental Disorders Diagnosed in Childhood
Movement Disorders
Nervous System Diseases
Neurodegenerative Diseases
Tic Disorders
Interventions listed in this trial
placebo
Additional drug interventions recognized in this trial
Dihydroxyphenylalanine
Dopamine
Dopamine Agents
Dopamine Agonists
Levodopa
More general drug interventions related to this trial
Anti-Dyskinesia Agents
Antiparkinson Agents
Autonomic Agents
Cardiotonic Agents
Cardiovascular Agents
Central Nervous System Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Sympathomimetics
Therapeutic Uses
Sponsors listed in this trial
Kevin J. Black, MD
National Institute of Mental Health (NIMH)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services